
Contact us
About company
MEDPNC specializes in studying personalized treatments for cancer by analyzing the patient-specific protein network structures. It develops a method that proposes the optimal drug combination for each individual patient and also predicts the efficacy of the treatment. MEDPNC was founded in 2013 and is headquartered in Herzliya, Israel.
DE
Unknown
Not verified company